Le Lézard
Classified in: Health, Business
Subjects: NPT, FNC, HSP, WOM, BLK, TRI, LGB, DEI

PCORI approves $254 million to fund 28 new research studies addressing urgent health problems


WASHINGTON, July 27, 2021 /PRNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $254 million in funding for 28 new research studies aimed at eliminating disparities in maternal and infant health, preventing suicide among young people, and improving behavioral health, cancer care, surgical care and outcomes for people with chronic illnesses such as cardiovascular disease and diabetes.

"These awards present significant opportunities to address pressing health challenges and empower patients and their families with actionable information about their healthcare choices," said PCORI Executive Director Nakela L. Cook, M.D., M.P.H. "We are pleased to fund several studies that confront critical evidence needs to reduce disparities in maternal morbidity and mortality and improve outcomes for people living with intellectual and developmental disabilities, two of PCORI's priority areas for research."

Four studies approved for a total of $33 million will assess interventions to improve care during pregnancy and after childbirth to reduce the higher rates of health problems among Black women and Latinas and their infants. The largest will compare approaches to reducing the risk of low birth weight among Black infants.

Five studies totaling $58 million will assess interventions to reduce suicide among adolescents and young adults, which is the second leading cause of death among U.S. youth ages 15-24. Three of these will compare whether tailoring prevention strategies leads to better outcomes among autistic youth, Alaska Native youth, and sexual and gender diverse young adults respectively.

Several funding awards support large, multiphase comparative clinical effectiveness research (CER) studies. The studies include:  

Two awards totaling $12 million will support studies assessing ways to deliver mental health care to young people with intellectual and developmental disabilities, who have higher rates of need and use of emergency care.

Details of these and other studies approved for funding by PCORI's Board today are on the website. All funding awards were approved pending a business and programmatic review by PCORI staff and issuance of formal award contracts. With these latest awards, PCORI has invested about $3.2 billion to fund patient-centered CER and to support other projects designed to enhance CER methods and the infrastructure necessary to conduct CER rigorously and efficiently.

About PCORI 
The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.

SOURCE Patient-Centered Outcomes Research Institute


These press releases may also interest you

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...



News published on and distributed by: